SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Metropolis Healthcare

BSE: 542650 22 Aug 2025
Healthcare
₹ 2158.1
Metropolis Healthcare Limited specializes in Healthcare Service Provider within the Healthcare sector.

Metropolis Healthcare - Share Price & Details

Market Cap
₹11,165
High /Low
2,318 / 1,315
Stock P/E
73.4
Book Value
₹257.0
Dividend Yield
0.19
ROCE
14.7
ROE
₹11.5
Face Value
2.0
PEG Ratio
-6.31
EVEBITDA
₹33.9
Debt
204
CMP / FCF
56.7
Debt to equity
₹0.15
NP Ann
146
High price all time
3,580
Piotroski score
₹4.0
Graham Number
413.0
No. Eq. Shares
5.18
Net CF
₹-23.1
Net profit
153
Price to book value
8.39
Interest Coverage
₹11.5
Low price all time
905.0
Industry PE
40.5
Reserves
₹1,321
Free Cash Flow
₹196

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
Metropolis Healthcare Limited3264.12355.823236.326.8411,16573.4
Vijaya Diagnostic Centre Limit1822.68383.891748.453.731050269.6
PROCTER & GAMBLE HEALTH LIMITE3427.7661.83387.439.871049634.9

Peer Comparison Chart


About Metropolis Healthcare

Metropolis Healthcare Limited, with Security Code 542650, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Golden Crossovers: Metropolis Healthcare, Dixon Tech among 5 stocks signal further bullishness on August 12

(12 Aug 2025)
In the NSE list of stocks with a market cap of over Rs 1000 crore, five stocks are witnessing Golden Crossovers, according to...
Read more →

Metropolis Healthcare targets over 12% organic growth in FY26

(10 Aug 2025)
Metropolis' TruHealth preventive health check-up business has been growing 22–25% annually for the past three years.
Read more →

Metropolis Q1FY26 revenue up 23% YoY, PAT rises 19% to ₹45 Cr

(09 Aug 2025)
Metropolis Healthcare Q1FY26 Results: Metropolis Healthcare Limited reports significant growth in Q1FY26, with patient volumes up by 11% and...
Read more →

Metropolis Healthcare reports Q1 FY26 PAT higher by 19% at Rs. 45 Cr

(08 Aug 2025)
Ameera Shah-led Metropolis Healthcare Limited, India's second-largest and most respected pathology laboratory chain, announced its unaudited...
Read more →

Metropolis Healthcare to convene board meeting

(08 Aug 2025)
Metropolis Healthcare will hold a meeting of the Board of Directors of the Company on 7 August 2025.
Read more →

Metropolis Healthcare Limited (METROPOLIS) Quarterly Results Are Out - Capitalize on momentum-driven investment opportunities

(06 Aug 2025)
Metropolis Healthcare Limited (METROPOLIS) Quarterly Results Are Out ✌️【Growth Stocks】✌️ Achieve financial goals faster with actionable...
Read more →

Company Updates